Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

Bibliográfalaš dieđut
Váldodahkkit:	Flossmann, O, Jones, R, Jayne, DR, Luqmani, R
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2006

Geahča maid

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2006)

Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2008)

Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
Dahkki: Saket Jha, et al.
Almmustuhtton: (2019-01-01)

Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Dahkki: Zhi-Ying Li, et al.
Almmustuhtton: (2020-08-01)

A Case of Postcoronavirus Disease 2019 Antineutrophil Cytoplasmic Antibody-associated Vasculitis Successfully Treated with Rituximab
Dahkki: Mahmoud M. Mohamed, et al.
Almmustuhtton: (2023-07-01)

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
Dahkki: Walsh, M, et al.
Almmustuhtton: (2011)

Glucocorticoid Treatment and Damage In The Antineutrophil- Cytoplasm Antibody Associated Vasculitides
Dahkki: Robson, J, et al.
Almmustuhtton: (2013)

Early outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis
Dahkki: Morishita, K, et al.
Almmustuhtton: (2017)

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.
Dahkki: Guerry, M, et al.
Almmustuhtton: (2012)

Serum calprotectin in vasculitis associated with antineutrophil cytoplasmic antibodies
Dahkki: E. N. Vorkel, et al.
Almmustuhtton: (2024-08-01)

The role of neutrophils in vasculitis associated with antineutrophil cytoplasmic antibodies
Dahkki: E. N. Vorkel, et al.
Almmustuhtton: (2024-12-01)

Nailfold videocapillaroscopy in antineutrophil cytoplasmic antibody–associated vasculitis
Dahkki: Megan M. Sullivan, et al.
Almmustuhtton: (2024-01-01)

Health-related quality of life after Rituximab treatment of patients with antineutrophil cytoplasmic antibody-associated vasculitis
Dahkki: Iva Parvova, et al.
Almmustuhtton: (2024-11-01)

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
Dahkki: De Groot, K, et al.
Almmustuhtton: (2005)

Antineutrophilic Cytoplasmic Antibody Positive Vasculitis Associated with Methimazole Use
Dahkki: Deep Shikha, et al.
Almmustuhtton: (2015-01-01)

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2008)

Relapse Predictors in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
Dahkki: Katarzyna Wawrzycka-Adamczyk, et al.
Almmustuhtton: (2024-08-01)

Minocycline-induced antineutrophil cytoplasmic antibody-associated vasculitis in children
Dahkki: Sunil Kapur, et al.
Almmustuhtton: (2021-01-01)

Recent advances in the management of antineutrophil cytoplasmic antibody-associated vasculitis
Dahkki: Durga Prasanna Misra, et al.
Almmustuhtton: (2019-01-01)

Profiles of cytokines in patients with antineutrophil cytoplasmic antibody-associated vasculitis
Dahkki: Weiwei Hao, et al.
Almmustuhtton: (2024-07-01)

Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
Dahkki: Noah Huizenga, et al.
Almmustuhtton: (2020-04-01)

Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis
Dahkki: T V Beketova
Almmustuhtton: (2018-05-01)

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis
Dahkki: Weiran Li, et al.
Almmustuhtton: (2021-03-01)

Rituximab in relapsed/refractory antineutrophil cytoplasmic antibody associated vasculitis: A single-center prospective observational study
Dahkki: Ekbote Gayatri, et al.
Almmustuhtton: (2019-01-01)

Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody–Associated Vasculitis: Systematic Review and Meta‐Analysis
Dahkki: Valérie Bénard, et al.
Almmustuhtton: (2021-07-01)

A severe, antineutrophil cytoplasmic antibody associated, anterior segment vasculitis.
Dahkki: Talks, S, et al.
Almmustuhtton: (1994)

Steroid-sparing strategy for the treatment of vasculitis associated with antineutrophil cytoplasmic antibodies
Dahkki: O. N. Egorova, et al.
Almmustuhtton: (2024-10-01)

Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis.
Dahkki: Sourabh Chand, et al.
Almmustuhtton: (2013-01-01)

Treatment With Avacopan in Patients With Respiratory Tract Manifestations of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
Dahkki: Ulrich Specks, et al.
Almmustuhtton: (2025-01-01)

Antineutrophil cytoplasmic antibody-associated vasculitis in a patient with diffuse scleroderma
Dahkki: B N Shiva Prasad, et al.
Almmustuhtton: (2021-01-01)

The changing paradigm of glucocorticoid therapy in antineutrophil cytoplasmic antibody-associated vasculitis
Dahkki: Kunal Chandwar, et al.
Almmustuhtton: (2022-01-01)

Malignancy is increased in patients with antineutrophil cytoplasmic antibody-associated vasculitis in China
Dahkki: Xiang-Yu Han, et al.
Almmustuhtton: (2024-05-01)

Treatment of severe perinuclear antineutrophil cytoplasmic antibody–associated vasculitis with efgartigimod
Dahkki: Afsoon Ghafari-Saravi, BS, et al.
Almmustuhtton: (2024-05-01)

Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives
Dahkki: Zdenka Hruskova, et al.
Almmustuhtton: (2020-02-01)

OMERACT endorsement of patient-reported outcome instruments in antineutrophil cytoplasmic antibody–associated vasculitis
Dahkki: Robson, J, et al.
Almmustuhtton: (2017)

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
Dahkki: de Groot, K, et al.
Almmustuhtton: (2009)

Antineutrophil cytoplasmic antibody-associated vasculitis, update on molecular pathogenesis, diagnosis, and treatment
Dahkki: Arman F, et al.
Almmustuhtton: (2018-11-01)

Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis
Dahkki: Chand, S, et al.
Almmustuhtton: (2013)

A Tangled Autoimmune Trio: Multiple Sclerosis, Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antineutrophil Cytoplasmic Antibody Vasculitis
Dahkki: Rajaie Namas, et al.
Almmustuhtton: (2023-10-01)

Cardiovascular disease and antineutrophil cytoplasmic antibodies-associated vasculitis: A systematic review
Dahkki: Amal H. Mohamed, et al.
Almmustuhtton: (2024-08-01)